Summary: Single-photon emiSSIOn computed tomog raphy (SPECT) was used for the measurement of regional cerebral blood volume (CBV) and hematocrit (Hct) in normal healthy human volunteers (mean age 30 ± 8 years), Regional cerebral red blood cell (RBC) volume and plasma volume were determined separately and their responses to carbon dioxide were investigated, Ten right handed healthy volunteers were the subjects studied, SPECT scans were performed following intravenous in jection of the RBC tracer (99mTc-Iabeled RBC) and plasma tracer (99ffiTc-labeled human serum albumin) with an in terval of 48 h, Regional cerebral Hct was calculated as the regional ratio between RBC and plasma volumes and then was used for calculating CBV, Mean regional CBV in the resting state was 4,81 ± 0,37 ml/IOO g brain, sig nificantly greater in the left hemisphere compared with Blood volume and hematocrit (Hct) are known to be important in the regulation of cerebral circula tion, To mographic measurements of circulating red blood cells (RBC) in the brain, labeled either with positron-or single-photon-emitting tracers, have been used to display a three-dimensional distribu tion of cerebral blood volume (CBV) in humans (Kuhl et aI., 1975; Grubb et aI., 1978; Phelps et aI., 1979). When the method utilizes labeled RBC as a tracer for the determination of whole-blood volume in the brain, obtained CBV values must be cor rected for the cerebral Hct. Although it is known that the brain Hct is lower than the large-vessel 
Blood volume and hematocrit (Hct) are known to be important in the regulation of cerebral circula tion, To mographic measurements of circulating red blood cells (RBC) in the brain, labeled either with positron-or single-photon-emitting tracers, have been used to display a three-dimensional distribu tion of cerebral blood volume (CBV) in humans (Kuhl et aI., 1975; Grubb et aI., 1978; Phelps et aI., 1979) . When the method utilizes labeled RBC as a tracer for the determination of whole-blood volume in the brain, obtained CBV values must be cor rected for the cerebral Hct. Although it is known that the brain Hct is lower than the large-vessel Paco2) were significantly greater than for RBC volume (1.46 ± 0.48%/mmHg Paco2), Consequently, the cerebral to-large-vessel Hct ratio was reduced to 72.4 ± 2,2%, Results emphasize the importance of cerebral Hct for the measurement of CBV and indicate that regional cerebral Hcts are not constant when shifted from one physiolog ical state to another. Key Words: Cerebral blood volume-Cerebral hematocrit-Single-photon emission computed tomography, Hct, until the present study no tomographic studies in humans had been undertaken to measure regional cerebral Hct values. Previous authors have used a value of 0.85 for the cerebral-to-Iarge-vessel Hct ratio, This was suggested by Phelps et al. (1973) as the standard value based on the best available evi dence in the literature.
The purpose of the present investigation was to determine whether cerebral Hct measured by three dimensional techniques in normal human volun teers give comparable values to previously reported values obtained either by global or two-dimensional techniques in humans (Larsen and Lassen, 1964; Oldendorf et aI., 1965) or by tissue-sampling tech niques in experimental animals (Gibson et aI., 1946; Everett et aI., 1956; Sklar et aI. , 1968; Levin and Ausman, 1969; Cremer et aI. , 1983) . The question of whether or not regional cerebral Hct might show variations during different physiological conditions was also examined. Single-photon emission com-puted tomography (SPECT) was used for measuring regional CBV and Hct in humans. Both regional ce rebral RBC volume and plasma volume were deter mined in each subject, and any changes during 5% CO2 inhalation were measured.
SUBJECTS AND METHOD
CBV and Hct were measured in 10 right-handed neu rologically normal healthy male volunteers aged 24-41 years (mean ± SD 30 ± 8 years). SPECT scans of the head were performed on each subject following the intra venous injection of 99mTc-Iabeled RBC for measurement of regional RBC volume and of 99mTc-Iabeled human serum albumin (HSA) for measurement of regional ce rebral plasma volume. These two studies were performed separately after an interval of 48 h. Serial scans were made in each study in the resting state and repeated during inhalation of 5% CO,. To maintain the subjects in the same physiological con-ditions during the RBC and the HSA study, they were allowed to lie quietly until the blood pressure and the arterial CO, reached steady-state condition. The first scan was made 15 min after the in travenous injection of the tracer. The second study was performed 10 min after the completion of the first study. The inhalation of 5% COc was started 2 min prior to and was continued throughout the second study. At the time of each scan, arterial blood samples were withdrawn through an indwelling catheter for the measurement of Paco2 and large-vessel Hct, and the blood pressure was also measured.
after the injection of 99mTc-Iabeled HSA, revealed that the mean label ratio for albumin in the circulating blood was 96.1 ± 2.4% (n = 5). The scan time for both RBC and HSA studies was 10 min, and �2,500,000 counts was collected in that interval. Arterial blood samples were taken during each scan, and radioactivities for both RBC and plasma were determined. Measured concentrations of blood radioactivity were used for calculation of CBV and brain Hct.
CBV was calculated by Eq. 1, which gives the ratio of the 99mTc activity per weight of brain to the estimated 99mTc activity per milliliter of cerebral whole blood:
where C br ain is the activity per gram of brain determined by scanning and the denominator is the activity of cere bral whole blood estimated from arterial blood counts.
C rbc and C plasma are the activities per milliliter of RBC and plasma in the sampled arterial blood, respectively; Hct is the large-vessel arterial Hct measured from drawn arterial blood samples. The constant ex represents the ratio of the cerebral small-vessel Hct to the large-vessel Hct, and the product of 100 converts CBV values to milliliters per 100 g brain. The constant ex was determined by Eq. 2, which com pares the data between [99mTcjRBC and [99mTcjHSA studies:
The SPECT system used for the present study was a GE Maxi 400T camera connected to an Informatek Simis 3 computer system. The radius for the rotation of the camera was set at 25 cm, and the data were collected through 64 equal angular samplings. A low-energy, high resolution collimator was used. The blood volume images were reconstructed in a series of horizontal sections of the brain parallel to the anatomical line (Reid's line) for every 1.2 cm from the vertex (Fig. 1) . A filtered back projection method was used, with a value of 0.15 for the attenuation correction. The spatial resolution measured in a skull phantom, expressed by the full width half-max imum of the profile, was 1.7 cm, and the cold lesion de tectability was a cylinder measuring 2 cm in diameter. The brain scans were calibrated by matching to the scan of a skull phantom filled with water and a pack of 99mTc_ labeled human blood of known radioactivity. For the RBC volume study, a sample of the subject's RBC was labeled with �20 mCi of 99mTc using stannous pyrophosphate as a reducing agent, and was injected as the RBC tracer into an antecubital vein. For plasma volume measurements, 20 mCi of 99mTc-Iabeled HSA was used as the plasma tracer. The label ratio for RBC remained constant during the first hour at 97.2 ± 1.2% (n = 10). The radioactivity of labeled albumin reached a plateau within 7 min fol lowing intravenous injection, then stayed constant there after for an interval of 45 min. A study by gel partition chromatography for plasma samples, obtained 45 min
where the left term is the CBV value calculated by the [99mTcjRBC study and the right term is the CBV value by the [99mTcjHSA study. If Eq. 1 is applied to both [99mTcjRBC and [99mTcjHSA studies for the calculation of CBV, the results should give the same CBV value if the correct ex is used in the equation. The coefficient of ex can be calculated from Eq. 2, in which ex is the only variable. The calculated ex value can then be put in Eq. 1 for the determination of corrected CBV, cerebral RBC volume, and cerebral plasma volume. Figure 2 illustrates the images for cerebral RBC volume, cerebral plasma volume, calculated Hct, and CBV.
The coefficient of variation of hemispheric average CBV values for repeated measurements of the same slice was 2.6%, and the average variation from one measure ment to another was 0.12 ± 0.03 (mean ± SD) ml/100 g brain. There was no tendency for increased accumulation of radioactivity during the second scan.
Since all CO, runs were performed as second runs, we examined the possibility of overestimations of the in creases in plasma volume during the second run owing to an increase in unlabeled 99mTc that may have accu mulated in the vessel. This possibility, however, was con sidered to be unlikely for two reasons. First, the coeffi cient of variation for the repeated measurements with plasma tracer was 2.9%, which was as good as that of 2.4% with the RBC tracer. Second, we measured the CO2 responsiveness in three additional subjects during hyper- ventilation, in which the change (reduction) in the plasma volume was also greater than that in the RBC volume seen during 5% CO2 inhalation (see Results). The data derived from the hyperventilation studies were not in cluded among the results of the present study for the determination of CO2 responsiveness because of the dif ficulty in obtaining a constant Pac02 level over the IO-min hyperventilation studies.
RESULTS
Steady-state values for regional CBV and regional HCT Table I summarizes mean hemispheric regional CBV and Hct values among the 10 right-handed healthy volunteers. The values represent the mean of four horizontal slices between 4.2 and 7.8 cm below the vertex. This includes large areas of ce rebral cortex, subcortex, white matter of the cen trum semiovale, gray matter of the basal ganglia, thalamus, and brainstem structures above the mid brain. The mean of the regional CBV values was 4.81 ± 0.37 mlllOO g brain. The blood volume for the left hemisphere (4.89 ± 0.37 mill 00 g brain) was significantly greater than for the right hemisphere (4.71 ± 0.39 mlllOO g brain) by 3.8% at p < 0.01 (paired t test). The mean for regional RBC volumes in the resting state was 1.50 ± 0.09 mlllOO g brain. This was significantly smaller than the mean of the plasma volumes, which was 3.34 ± 1.8 mlllOO g brain. The mean cerebral Hct calculated from these values was 31.3 ± 1.8%, and the mean ratio of the cerebral to the large-vessel Hct was 75. 9 ± 2.1%. Both RBC volume and plasma volume were greater in the left hemisphere than in the right, but only the difference in the plasma volume reached the level of significance (p < 0.01).
Effect of hypercarbia on regional CBV and MABP Figure 3 illustrates the effect of 5% CO2 inhala tion on mean cerebral RBC volume and mean ce rebral plasma volume, and Ta ble 2 summarizes changes in regional CBY during 5% CO2 inhalation. During 5% CO2 inhalation, the volume was in creased in both RBC and plasma, but the increase was greater for plasma volume than for RBC volume. When expressed as the percentage in crease of volume per mmHg Paco2 increase, the increase in the RBC volume was 1.45 ± 0.48 /1%/ mmHg P aco2' and the increase in the plasma volume was 2.81 ± 1.04 /1%/mmHg Paco2. The dif ference in CO2 responsiveness between the RBC volume and the plasma volume was significant at the p < 0.01 level. Since changes in Paco2 and MABP during 5% CO2 inhalation were identical for both RBC and plasma studies for each individual, the responses of CBY and Hct to the changes in Paco2 were also calculated ( Table 2 ). The increase in CBY was 2.34 ± 0.94 /1%/mmHg Paco2, and the cerebral Hct was reduced significantly from the steady-state value of 31.3 ± 1.8% to 30.3 ± 0. 9% during 5% CO2 inhalation (p < 0.05 by paired t test).
Since CBV is known to respond not only to changes in Paco2 but also to changes in MABP, a bivariate analysis including both of these parame- ters as an independent variable was performed, and Eq. 3 was obtained:
where CBV is in milliliters per 100 g brain. The overall fit of Eq. 3 was significant at the p < 0.01 level. For the purpose of comparison with sim ilar equations in the literature, the same analysis was applied to CBV values calculated only by the data in the [99mTc]RBC study, using a standard ce rebral-to-large-vessel Hct ratio of 0.85 (85.0%), and Eq. 4 was obtained:
where CBV is in milliliters per 100 g brain.
DISCUSSION

Regional CBV
The present study emphasizes the importance of measurements of cerebral Hct in the same subjects for accurate calculation of CBV values, and cau tions against calculation of regional CBV using an arbitrary and/or fixed cerebral-to-large-vessel Hct ratio. Quantitative tomographic measurements of regional CBV in humans by emission computed to mography was first reported by Kuhl et al. (1975) utilizing 99mTc-Iabeled RBC as a single-photon emitting tracer. More recently, regional CBV has C Ratio of cerebral to large-vessel Hc!.
been determined by positron emission tomography using lICO-labeled RBC (Grubb et al.. 1978; Phelps et aI., 1979) . Hitherto reported values for CBV mea sured by RBC tracers show only small variations among authors: 4.2 ± 0.4 ml/lOO g brain by Phelps et al. (1979) using [IICO]RBC, 4.3 ± 0.41 ml/lOO g brain by Grubb et al. (1978) using [IICO]RBC, and 4.34 ± 0.5 ml/lOO g brain by Kuhl et al. (1980) using [99mTc] RBc. On the other hand, a higher value of 5.7 ± 0.6 mi/lOO g brain was reported in the monkey by a method using the plasma tracer Re nographin 76 (Phelps et aI., 1973) . All of these au thors used a cerebral-to-large-vessel Hct ratio of 0.85 for the correction of CBV, which was obtained by averaging the cerebral Hct values in the litera ture (Phelps et aI., 1973) . The mean CBV value of 4.81 ± 0.37 ml/lOO g brain reported here is higher than any values measured by RBC tracer and lower than values measured by plasma tracers. However, if CBV were calculated by our data obtained in the [99mTc]RBC study with the correction using a ce rebral-to-large-vessel Hct ratio of 0.85, the mean CBV was 4.30 ± 0.32 ml/l00 g brain, which shows closer agreement with previously reported values measured by RBC tracers. The same situation ap plies to the data for the present plasma tracer mea surements. If CBV is calculated using our data ob tained in the plasma tracer study with a cerebral to-large-vessel Hct ratio of 0.85, a value of 5.13 ± 0.41 ml/IOO g brain is obtained. This is in good agreement with the relatively high value measured by a plasma tracer (Phelps et aI., 1979) . Therefore, the discrepancy between our CBV value and those of previous authors may well be explained by dif ferences in the cerebral-to-Iarge-vessel Hct ratio, which must be calculated for each method and cannot be assumed to be fixed. Significantly greater CBV values were measured in the left cerebral hemisphere compared with the right in our volunteers, all of whom were right handed and may be assumed to have predominantly left cerebral dominance. The present results are in agreement with those of Grubb et al. (1978) , but Kuhl et al. (1980) did not find consistent CBV dif ferences between left and right hemispheres. No conclusive explanation can be offered for this dis crepancy, but it is possible that differences in the steady-state conditions in different laboratories may account for the different results reported (e.g., speaking to the patients, asking them to move their right hands, etc.). It is worthy of note that the hemi spheric difference was more marked for plasma volume than for RBC volume. It seems reasonable to suggest that an increase in CBV in physiological conditions may be associated with more marked in creases in the plasma component.
Regional cerebral Hct
The present results demonstrate the feasibility of quantitative measurements of regional cerebral Hct in humans using SPECT. They also suggest that the method can detect variations of cerebral Hct during different physiological conditions. The cerebral-to large-vessel Hct ratio in the present study was 75.9 ± 2.1%, as summarized in Ta ble 1. As this is the first report in the literature of three-dimensional measurements of cerebral Hct in a series of normal human volunteers, the present results were com pared with earlier reports on global or two-dimen sional measurements of cerebral Hct in humans and with measurements in experimental animals. De spite the fact that most of the previous studies used similar types of tracers, namely, labeled RBC and albumin, there are wide variations among reported values concerning the ratio of cerebral-to-large vessel Hct, ranging from 0.41 to 0.92 (Gibson et aI., 1946; Everett et aI., 1956; Larsen and Lassen, 1964; Oldendorf et aI., 1965; Sklar et aI., 1968; Levin and Ausman, 1969; Cremer et aI., 1983) . The present values for the cerebral Hct ratio were lower than two reported values of global cerebral measure ments in humans, i.e., 0.92 from Larsen and Lassen (1964) and 0.84 from Oldendorf et al. (1965) . The present results agree well with those of Cremer et al. (1983) and Sklar et al. (1968) , who employed direct tissue-sampling techniques in experimental animals and obtained cerebral Hct ratios of 0.70 and 0.74, respectively. Our value also compares well with that of 0.69 measured by positron emission tomography in eight patients with various neurolog ical disorders and one normal subject (Lammertsma et aI., 1984) . Since the average Hct of the capillary blood is known to be less than that of blood in large diameter vessels as reported by Fahraeus (1929) , lower Hct values should be expected if tissue sam ples include more capillaries and arterioles. It is likely that measurements of cerebral Hct with three-dimensional resolution by the present method or by positron emission tomography (Lammertsma et aI., 1984) are representing more regional values than previously reported by two-dimensional or whole-brain measurements in humans. Since three dimensional values for cerebral Hct are obviously essential for determining three-dimensional regional CBV values in humans, accurate measurements of regional CBV with emission computed tomography can best be accomplished by sequential measure ments of RBC and plasma volume in the same pa tients.
Testing changes of CBV and Hct by hypercarbia
The measurement of the responsiveness of CBV to alterations in Pa co2 and blood pressure provides a potential method for quantitating cerebral vas cular reactivity. Bivariate analysis in the present study revealed a positive correlation between CBV and P aco2 and an inverse correlation between CBV and MABP. This indicates normal cerebral vasodi latory responses to increases in P aco2 with pre served cerebral autoregulatory responses to in creases in MABP. Greenberg et al. (1978) , using [99mTc]RBC as a tracer, performed tomographic measurements of local CBV responses to carbon dioxide in humans and reported a value of 0.0495 ml/l00 g brain/mmHg Pa c02 or a 1.225% change per mmHg Pa co2. Their values were in good agreement with previous re ports of CBV responses to carbon dioxide inhala tion in experimental studies, which ranged from 0.041 to 0.049 mlllOO g brain/mmHg Pa co2 (Smith et aI., 1971; Phelps et aI., 1973; Grubb et aI., 1974; Kuhl et aI., 1975) . The CO2 responsiveness of CBV in the present study, as calculated in Eq. 3, was 0.10 mlll00 g/mmHg Pa co2, and was greater than the previously reported results. However, if CBV was calculated using only the data from the RBC tracer studies as did previous authors, then CO2 responsiveness was 0.05 mlil00 g brain/mmHg Pa co2, as derived from Eq. 4. This value is in good agreement with those of Greenberg et al. (1978) and others. Thus, the greater responsiveness of CBV to CO2 in the present study is attributed to greater increases in plasma than in RBC volume during 5% CO2 inhalation. As a result of this difference be tween RBC and plasma volume, cerebral Hct was reduced during 5% CO2 inhalation.
A good agreement between our values on CO2 responsiveness by either RBC or plasma tracer and previously reported values by three-dimensional measurements may be taken as additional evidence for validation of the present measurement. The exact isolation of the intracerebral from the extra cranial tissue by selecting the region of interest in the present method may not be as precise as that in studies using positron emission tomography in which the superposition of the brain image by l18F]fluorodeoxyglucose in the same subject is pos sible (Kuhl et al., 1980) . However, cerebral gray and white matter were considered to be the main constituents of the blood volume measured in the present method, since blood volume of extracranial structures should show little or no reaction to changes in P aco2 (Heistad et aI., 1977) .
Cerebral Hct was found to be reduced further during 5% CO2 inhalation. To the best of our knowl edge, there has been no observation reported in the literature of changes in cerebral tissue Hct during vasodilatation associated with an increase in Pa co2• The interpretation of the mechanism for this Hct change should then be based on previous hem or rheological studies. Studies on microcirculation have shown that if flow rates increase in small ves sels and capillaries during vasodilatation, increased shear on cellular orientation and deformation lead to more cellular migration toward the tube axis and faster RBC flow, which consequently results in a reduced Hct (Gaehtgens et aI., 1978) . Other pos sible mechanisms for the reduction of Hct include a disproportional inflow of fluid from the interstitial fluid space during vasodilatation. The most likely explanation is the possibility that arterial vasodila tation may increase the number of open capillary channels available for plasma passage, with more plasma skimming and a decrease in tissue Hct (Ro senblum, 1972) .
